These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 27329280

  • 1. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
    Winner P, Farkas V, Štillová H, Woodruff B, Liss C, Lillieborg S, Raines S, TEENZ Study Group.
    Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
    [Abstract] [Full Text] [Related]

  • 2. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 Jul; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 3. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 Jul; 17(9):653-67. PubMed ID: 12828501
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
    Diener HC, Evers S.
    Clin Drug Investig; 2007 Jul; 27(1):59-66. PubMed ID: 17177580
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M, Hee A, Emeribe U, Silberstein S.
    CNS Drugs; 2006 Jul; 20(12):1019-26. PubMed ID: 17140280
    [Abstract] [Full Text] [Related]

  • 10. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM.
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [Abstract] [Full Text] [Related]

  • 11. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J.
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Zolmitriptan for acute migraine attacks in adults.
    Bird S, Derry S, Moore RA.
    Cochrane Database Syst Rev; 2014 May 21; 2014(5):CD008616. PubMed ID: 24848613
    [Abstract] [Full Text] [Related]

  • 14. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
    Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ.
    Headache; 2009 Oct 21; 49(9):1315-23. PubMed ID: 19788472
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ, Dodick DW, Schmidt PC, Kellerman DJ.
    Headache; 2019 Apr 21; 59(4):509-517. PubMed ID: 30698272
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan 21; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 18. A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extension.
    Yonker ME, McVige J, Zeitlin L, Visser H.
    Headache; 2022 Oct 21; 62(9):1207-1217. PubMed ID: 36286602
    [Abstract] [Full Text] [Related]

  • 19. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
    Rapoport AM, Mathew NT, Silberstein SD, Dodick D, Tepper SJ, Sheftell FD, Bigal ME.
    Neurology; 2007 Aug 28; 69(9):821-6. PubMed ID: 17724283
    [Abstract] [Full Text] [Related]

  • 20. Intranasal zolmitriptan for the treatment of acute migraine.
    Tepper SJ, Chen S, Reidenbach F, Rapoport AM.
    Headache; 2013 Sep 28; 53 Suppl 2():62-71. PubMed ID: 24024604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.